| 000 | 01632 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250515052627.0 | ||
| 264 | 0 | _c20070124 | |
| 008 | 200701s 0 0 eng d | ||
| 022 | _a0013-9580 | ||
| 024 | 7 |
_a10.1111/j.1528-1167.2006.00711.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aRistić, Aleksandar J | |
| 245 | 0 | 0 |
_aThe frequency of reversible parkinsonism and cognitive decline associated with valproate treatment: a study of 364 patients with different types of epilepsy. _h[electronic resource] |
| 260 |
_bEpilepsia _cDec 2006 |
||
| 300 |
_a2183-5 p. _bdigital |
||
| 500 | _aPublication Type: Comparative Study; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aAnticonvulsants _xadverse effects |
| 650 | 0 | 4 |
_aCognition Disorders _xchemically induced |
| 650 | 0 | 4 | _aDrug Administration Schedule |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 |
_aEpilepsy _xclassification |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aFollow-Up Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aLongitudinal Studies |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aParkinson Disease, Secondary _xchemically induced |
| 650 | 0 | 4 | _aPrevalence |
| 650 | 0 | 4 | _aSeverity of Illness Index |
| 650 | 0 | 4 | _aTreatment Outcome |
| 650 | 0 | 4 |
_aValproic Acid _xadverse effects |
| 700 | 1 | _aVojvodić, Nikola | |
| 700 | 1 | _aJanković, Slavko | |
| 700 | 1 | _aSindelić, Aleksandra | |
| 700 | 1 | _aSokić, Dragoslav | |
| 773 | 0 |
_tEpilepsia _gvol. 47 _gno. 12 _gp. 2183-5 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1528-1167.2006.00711.x _zAvailable from publisher's website |
| 999 |
_c16768122 _d16768122 |
||